Fetal cells in maternal blood: A six-fold increase in women who have undergone amniocentesis and carry a fetus with Down syndrome: A multicenter study

Neuropediatrics

Volumn 35, Issue 6, 2004, Pages 321-324

  Falcidia, E ^a   Parano, Enrico ^b   Grillo, A ^c   Pavone, P ^d   Takabayashi, H ^e   Trifiletti, R R ^f   Scollo, P ^g   Dallapiccola, B ^h,i   Grammatico, P ^h,i   Novelli, A ⁱ   Paladini, D ^j   Monni, G ^k   Gulisano, A ^d   Scassellati, C ^l  

^a Human Reproduction Medicine Unit   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c Human Genetic Laboratory   (Italy)

^d UNIVERSITY OF CATANIA   (Italy)

^e KANAZAWA MEDICAL UNIVERSITY   (Japan)

^f RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^g CANNIZZARO HOSPITAL   (Italy)

^h SAPIENZA UNIVERSITY OF ROME   (Italy)

ⁱ CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k Microcitemic Hospital   (Italy)

^l SAN CAMILLO FORLANINI HOSPITAL   (Italy)

more..

Author keywords

Down syndrome; Fetal nucleated red blood cells; Fetal nucleated red blood cells count (FNRBCC); General linear model; Screening method

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN SYNDROME; ERYTHROCYTE; FEMALE; FETUS; FETUS CELL; HUMAN; HUMAN CELL; MATERNAL BLOOD; MULTICENTER STUDY; MULTIPLE REGRESSION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL MODEL;

ADULT; AMNIOCENTESIS; CASE-CONTROL STUDIES; DOWN SYNDROME; ERYTHROBLASTS; ERYTHROCYTE COUNT; FEMALE; FETAL BLOOD; GESTATIONAL AGE; HUMANS; MALE; MATERNAL AGE; PREGNANCY;

EID: 19944367566     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-830365     Document Type: Article

References (10)

1. Al-Mufti R, Hambley H, Farzaneh F, Nicolaides K. Investigation of maternal blood enriched for fetal cells: role in screening and diagnosis of fetal trisomies. Am J Med Genet 1999; 85: 66-75
2. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 1997; 61: 822-829
3. Bianchi DW, Simpson JL, Jackson LG, Elias S, Holzgreve W, Evans MI, Dukes KA et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002; 22: 609-615
4. Cha D, Hogan B, Bohmer RM, Bianchi DW, Johnson KL. A simple and sensitive erythroblast scoring system to identify fetal cells in maternal blood. Prenat Diagn 2003; 23: 68-73
5. Farina A, Bianchi DW Fetal cells in maternal blood as a second non-invasive step for fetal Down syndrome screening. Prenat Diagn 1998; 18: 983-984
6. Merchant FA, Castelman KR. Strategies for automated fetal cell screening. Hum Reprod Update 2002; 8: 509-521
7. Parano E, Falcidia E, Grillo A, Takabayashi H, Trifiletti RR, Pavone P. Fetal nucleated red blood cell counts in peripheral blood of mothers bearing Down syndrome fetus. Neuropediatrics 2001; 32: 147-149
8. Pertl B, Bianchi DW. First trimester prenatal diagnosis: fetal cells in the maternal circulation. Semin Perinatol 1999; 23: 393-402
9. Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998; 1: 343-346
10. Wald NJ, Densem JW, Smith D, Klee GG. Four-marker serum screening for Down's syndrome. Prenat Diagn 1994; 14: 707-716